| abstract |
The invention relates to the following compounds of formula I, which is a potent inhibitor VCAM or α 4 β 1 mediated adhesion to CS-1 is useful for the treatment of inflammatory diseases:n n n (I)n n n n n n n n In particular, the molecules of the invention can be used to treat or prevent alpha 4 beta 1 mediated symptoms in mammals such as humans. The method can include administering to a mammalian or human patient an effective amount of a compound or composition described herein. |